CQS
BIIB icon

Credential Qtrade Securities’s Biogen BIIB Stock Holding History

Credential Qtrade Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17
Closed -$4.54K – 347
2022
Q3 		$4.54K Buy
+17
New +$3.61K ﹤0.01% 310
2022
Q1 		– Sell
-3
Closed -$719 – 362
2021
Q4 		$719 Buy
+3
New +$771 ﹤0.01% 369
2019
Q2 		– Sell
-710
Closed -$168K – 295
2019
Q1 		$168K Buy
710
+86
+14% +$27.1K 0.03% 172
2018
Q4 		$188K Sell
624
-237
-28% -$75.6K 0.04% 152
2018
Q3 		$304K Buy
+861
New +$296K 0.06% 145

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Credential Qtrade Securities's BIIB Position: Q4 2022 in Review

Credential Qtrade Securities sold out of Biogen (BIIB) in Q4 2022, closing a stake of 17 shares — an estimated $4.54K sold.

Credential Qtrade Securities first reported a position in BIIB in Q3 2018 and held it in 5 quarters. The position peaked at $304K in Q3 2018. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Credential Qtrade Securities reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • Credential Qtrade Securities sold 17 Biogen shares in Q4 2022, an estimated $4.54K.
  • Credential Qtrade Securities first reported a position in Biogen in Q3 2018 and held it in 5 quarters.
  • Credential Qtrade Securities's Biogen position peaked at $304K in Q3 2018.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Credential Qtrade Securities's 13F filing for Q4 2022, filed 21 Jul 2025.